Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)
Status:
Completed
Trial end date:
2012-11-12
Target enrollment:
Participant gender:
Summary
Cadazolid is a new antibiotic developed for the treatment of Clostridiun difficile associated
diarrhea (CDAD), also known as Clostridium Difficile Infection (CDI). The purpose of the
study was to evaluate the efficacy and safety of different doses of cadazolid in order to
find the dose of cadazolid to be used for further clinical development of the compound in
subjects with CDAD.